Derivation of RNA aptamer inhibitors of human complement C5
- 1 May 1999
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 42 (1-3), 219-230
- https://doi.org/10.1016/s0162-3109(99)00020-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITYAnnual Review of Immunology, 1998
- Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.Journal of Clinical Investigation, 1997
- Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic strokeJournal of Neurosurgery, 1997
- Requirement and role of C5a in acute lung inflammatory injury in rats.Journal of Clinical Investigation, 1996
- Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth FactorBiochemistry, 1995
- COMPLEMENT IN ORGAN TRANSPLANTATION CONTRIBUTIONS TO INFLAMMATION, INJURY, AND REJECTIONTransplantation, 1995
- The Contribution Of Terminal Complement Components To Acute And Hyperacute Allograft Rejection In The RatTransplantation, 1995
- Complement Activation and Inhibition in Myocardial Ischemia and Reperfusion InjuryAnnual Review of Pharmacology and Toxicology, 1994
- Characterization of an in vitro-selected RNA ligand to the HIV-1 rev proteinJournal of Molecular Biology, 1994
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990